Bill Text: NY S01001 | 2023-2024 | General Assembly | Amended


Bill Title: Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Passed) 2024-06-28 - SIGNED CHAP.152 [S01001 Detail]

Download: New_York-2023-S01001-Amended.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                         1001--A
            Cal. No. 164

                               2023-2024 Regular Sessions

                    IN SENATE

                                     January 9, 2023
                                       ___________

        Introduced by Sens. HOYLMAN-SIGAL, MAY, MYRIE, SALAZAR -- read twice and
          ordered  printed, and when printed to be committed to the Committee on
          Health -- recommitted to the Committee on Health  in  accordance  with
          Senate  Rule  6,  sec.  8  --  reported favorably from said committee,
          ordered to first and second report, ordered to a third reading, passed
          by Senate and delivered to the Assembly, recalled, vote  reconsidered,
          restored  to  third  reading, amended and ordered reprinted, retaining
          its place in the order of third reading

        AN ACT to amend the insurance law, in relation to  prohibiting  insurers
          from  restricting or imposing delays in the distribution of antiretro-
          viral prescription drugs to certain persons

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
     2  amended by adding a new paragraph 39 to read as follows:
     3    (39) No policy that provides coverage for antiretroviral  prescription
     4  drugs  prescribed for the treatment or prevention of the human immunode-
     5  ficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)  shall
     6  subject such drugs to prior authorization.
     7    § 2. Subsection (l) of section 3221 of the insurance law is amended by
     8  adding a new paragraph 22 to read as follows:
     9    (22) Every group or blanket policy delivered or issued for delivery in
    10  this  state that provides coverage for antiretroviral prescription drugs
    11  for the treatment or prevention  of  the  human  immunodeficiency  virus
    12  (HIV)  or  acquired  immunodeficiency  syndrome (AIDS) shall not subject
    13  such drug to a prior authorization requirement.
    14    § 3. Section 4303 of the insurance law is  amended  by  adding  a  new
    15  subsection (vv) to read as follows:
    16    (vv) Any contract issued by a medical expense indemnity corporation, a
    17  hospital  service  corporation  or  a  health  services corporation that
    18  provides coverage for antiretroviral prescription drugs for  the  treat-

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04099-03-4

        S. 1001--A                          2

     1  ment or prevention of the human immunodeficiency virus (HIV) or acquired
     2  immunodeficiency  syndrome (AIDS) shall not subject such drug to a prior
     3  authorization requirement.
     4    § 4. This act shall take effect on the one hundred eightieth day after
     5  it shall have become a law.
feedback